Orion Oyj ADR (ORINY)
Orion Oyj ADR is a depositary receipt tied to Orion Oyj’s common stock and listed on OTC Markets. Orion Oyj is a Finnish pharmaceutical company engaged in the development, manufacturing, and marketing of human and veterinary medicines, as well as active pharmaceutical ingredients. Its product range includes treatments used in oncology, Parkinson’s disease, pain management, menopausal symptoms, heart failure, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, and selected psychiatric conditions. The company also supplies veterinary medicines, contract manufacturing services, self-care products, and APIs for both generic and proprietary compounds. In addition, Orion sells products online and markets certain third-party medicines. Founded in 1917 and headquartered in Espoo, Finland, the company also maintains licensing arrangements with Tenax Therapeutics and Bayer related to specific development and commercialization programs.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ORIN.Y
|
$45.08
|
7.1% Upside
|
Fair
|
—
|
—
|
—
|
Great
|
—
|
—
|
0.51
|
1.3%
|
February 17, 2027
|
17.9x
|
8.3x
|
5.1x
|
12.092 B
|
11.994 B
|
1.2%
|
87.4%
|
13.6
|
41.3%
|
67.0%
|
